These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19596747)

  • 21. Kinnier Wilson's disease and Wilson's sign. S.A. Kinnier Wilson (1878-1937).
    Birch CA
    Practitioner; 1974 Feb; 212(1268):263-4. PubMed ID: 4610550
    [No Abstract]   [Full Text] [Related]  

  • 22. Wilson's disease: clinical management and therapy.
    Brewer GJ; Askari FK
    J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
    [No Abstract]   [Full Text] [Related]  

  • 23. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 24. New oral chelating agent for treatment of Wilson's disease.
    O'Reilly S; Bank W
    Nature; 1966 Dec; 212(5070):1597-8. PubMed ID: 21105526
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of treatment of Wilson's disease on natural history of haemochromatosis.
    Walshe JM; Cox DW
    Lancet; 1998 Jul; 352(9122):112-3. PubMed ID: 9672279
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of hepatolenticular degeneration (Wilson's disease).
    Traugh G
    Arch Phys Med Rehabil; 1971 Mar; 52(3):126-9. PubMed ID: 5575151
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease.
    Dixon HB; Gibbs K; Walshe JM
    Lancet; 1972 Apr; 1(7755):853. PubMed ID: 4111619
    [No Abstract]   [Full Text] [Related]  

  • 29. Wilson's disease and pregnancy.
    Sternlieb I
    Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
    [No Abstract]   [Full Text] [Related]  

  • 30. History of Wilson's disease: 1912 to 2000.
    Walshe JM
    Mov Disord; 2006 Feb; 21(2):142-7. PubMed ID: 16229009
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
    [No Abstract]   [Full Text] [Related]  

  • 33. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pregnancy in a patient treated with trientine dihydrochloride for Wilson's disease].
    Desbriere R; Roquelaure B; Sarles J; Boubli L
    Presse Med; 1998 May 2-9; 27(17):806. PubMed ID: 9767885
    [No Abstract]   [Full Text] [Related]  

  • 35. [Foreword. Wilson's disease].
    Woimant F
    Rev Neurol (Paris); 2013 Dec; 169(12):925-6. PubMed ID: 24239345
    [No Abstract]   [Full Text] [Related]  

  • 36. Chelating agents in the treatment of hepatolenticular degeneration (Wilson's disease).
    BLATTNER RJ
    J Pediatr; 1958 Jun; 52(6):758-61. PubMed ID: 13550045
    [No Abstract]   [Full Text] [Related]  

  • 37. Brief observations on the management of Wilson's disease.
    Walshe JM
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):1-3. PubMed ID: 122651
    [No Abstract]   [Full Text] [Related]  

  • 38. The story of penicillamine: a difficult birth.
    Walshe JM
    Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
    Grau-Veciana JM; Barraquer-Bordas L
    Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136
    [No Abstract]   [Full Text] [Related]  

  • 40. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.